Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 8, 2016 - Issue
Submit an article Journal homepage
109
Views
4
CrossRef citations to date
0
Altmetric
Original Research

A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

Josep Darbà1 Department of Economics, Universitat de BarcelonaCorrespondence[email protected]
,
Gabriela Ramírez2 BCN Health Economics & Outcomes Research SL
,
Juan L García-Rivero3 Hospital Laredo, Cantabria
,
Sagrario Mayoralas-Alises4 Hospital Ramón y Cajal, Madrid
,
José Francisco Pascual5 Hospital General Universitario de Alicante, Alicante
,
Albert Roger6 Hospital Universitario Germans Trias i Pujol, Barcelona
,
Diego Vargas7 Hospital de Alta Resolución el Toyo, Andalusia
&
Adi Bijedic8 Market Access and HEOR Department, TEVA Pharmaceutical, Madrid, Spain
 show all
Pages 435-444 | Published online: 06 Sep 2016

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas, José Francisco Pascual, Diego Vargas & Adi Bijedic. (2017) Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain. ClinicoEconomics and Outcomes Research 9, pages 127-137.
Read now

Articles from other publishers (3)

N. Roche, B. Aggarwal, I. Boucot, L. Mittal, A. Martin & H. Chrystyn. (2022) The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review. Respiratory Medicine 202, pages 106949.
Crossref
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin & Carolin Miltenburger. (2019) Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler. Applied Health Economics and Health Policy 18:3, pages 433-442.
Crossref
. (2016) DuoResp Spiromax forecast to save asthma costs in Spain. PharmacoEconomics & Outcomes News 762:1, pages 17-17.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.